Atlas Trials

Chidamide Maintenance to Prevent Relapse After Allogeneic Hematopoietic Stem Cell Transplantation in Acute T-Lymphoblastic Leukemia/Lymphoma

Clinical trial NCT07774377 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07774377
Sponsor
First Affiliated Hospital of Zhejiang University
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
T-Cell Acute Lymphoblastic LeukemiaT-Cell Lymphoblastic Lymphoma
Start date
2026-08-15
Primary completion
2028-08-15
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.